🔗 Share this article

Treasury head Rachel Reeves has stated she is preparing "specific steps to deal with cost of living challenges" in the upcoming financial statement.

In comments to media outlets, she noted that curbing price rises is a joint duty of both the administration and the central bank.

The UK's price growth is projected to be the most elevated among the G7 developed nations this calendar year and next.

Possible Energy Cost Measures

Sources suggest the administration could intervene to lower utility costs, for instance by cutting the current 5% rate of value-added tax charged on energy supplies.

A further approach is to reduce some of the regulatory levies presently added to bills.

Fiscal Constraints and Analyst Predictions

The government will obtain the next draft from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much space there is for such measures.

The view from most experts is that the Chancellor will have to announce higher taxes or expenditure reductions in order to meet her voluntary fiscal targets.

Previously on the same day, analysis showed there was a £22 billion shortfall for the chancellor to resolve, which is at the lower end of projections.

"It is a collective task between the Bank of England and the administration to bear down further on some of the causes of inflation," the Chancellor informed reporters in Washington, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Commitments and Global Concerns

While much of the focus has been on expected tax rises, the Treasury chief said the latest data from the fiscal watchdog had not altered her pledge to election pledges not to increase tax levels on earnings tax, sales tax or National Insurance.

She attributed an "unpredictable global environment" with growing geopolitical and trade issues for the fiscal revenue measures, probably to be directed on those "wealthiest."

International Economic Tensions

Commenting on worries about the UK's trade ties with China she said: "Our security interests invariably take priority."

Recent statement by China to tighten export controls on critical minerals and other resources that are key for high-technology production led US President Donald Trump to threaten an additional 100% tariff on goods from the Asian country, increasing the possibility of an full-scale commercial conflict between the two largest economies.

The American finance chief labeled the Chinese action "economic coercion" and "a international production power grab."

Inquired about accepting the American proposal to participate in its dispute with China, the Chancellor said she was "very concerned" by Chinese actions and urged the Chinese government "to avoid restrictions and limit trade."

She said the move was "damaging for the global economy and causes additional challenges."

"In my view there are fields where we must challenge Chinese policies, but there are also important opportunities to sell into China's economy, including banking sector and other sectors of the economic system. We've got to get that balance appropriate."

The Treasury chief also affirmed she was collaborating with other major economies "on our own critical minerals approach, so that we are more independent."

NHS Medicine Pricing and Funding

The Chancellor also acknowledged that the cost the National Health Service pays for drugs could increase as a result of current discussions with the Trump administration and its pharmaceutical firms, in return for reduced taxes and funding.

Some of the biggest global drug companies have said in recent statements that they are either halting or canceling operations in the United Kingdom, with some attributing the low prices they are obtaining.

Recently, the government science advisor said the cost the NHS pays for drugs would need to increase to prevent companies and pharmaceutical investment departing from the United Kingdom.

Reeves informed the BBC: "We have seen because of the cost structure, that clinical trials, new drugs have not been provided in the UK in the extent that they are in other continental states."

"The objective is to ensure that patients receiving treatment from the National Health Service are can access the top critical medicines in the globe. And so we are reviewing these issues, and... looking to obtain more investment into the UK."